XAV-19 / LFB SA, Xenothera  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
XAV-19 / LFB SA, Xenothera
POLYCOR, NCT04453384 / 2020-002574-27: Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia

Completed
2
416
Europe, RoW
XAV-19, Placebo
Nantes University Hospital, BPIfrance, Xenothera SAS
SARS Virus
05/21
08/21

Download Options